Bartlett & Co’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $2K | Sell |
87
-125
| -59% | -$2.58K | ﹤0.01% | 1141 |
|
|
2023
Q3 | $4K | Sell |
212
-40
| -16% | -$907 | ﹤0.01% | 1007 |
|
|
2023
Q2 | $6K | Sell |
252
-119
| -32% | -$3.13K | ﹤0.01% | 964 |
|
|
2023
Q1 | $11K | Sell |
371
-164
| -31% | -$4.76K | ﹤0.01% | 801 |
|
|
2022
Q4 | $14K | Sell |
535
-192
| -26% | -$4.7K | ﹤0.01% | 778 |
|
|
2022
Q3 | $16K | Sell |
727
-96
| -12% | -$2.51K | ﹤0.01% | 736 |
|
|
2022
Q2 | $23K | Buy |
823
+1
| +0.1% | +$29 | ﹤0.01% | 703 |
|
|
2022
Q1 | $28K | Buy |
+822
| New | +$26.5K | ﹤0.01% | 675 |
|
|
2021
Q4 | – | Sell |
-928
| Closed | -$29K | – | 439 |
|
|
2021
Q3 | $29K | Hold |
928
| – | – | ﹤0.01% | 587 |
|
|
2021
Q2 | $34K | Hold |
928
| – | – | ﹤0.01% | 557 |
|
|
2021
Q1 | $41K | Sell |
928
-1
| -0.1% | -$47 | ﹤0.01% | 569 |
|
|
2020
Q4 | $43K | Buy |
929
+1
| +0.1% | +$42 | ﹤0.01% | 543 |
|
|
2020
Q3 | $31K | Hold |
928
| – | – | ﹤0.01% | 555 |
|
|
2020
Q2 | $27K | Sell |
928
-114
| -11% | -$3.3K | ﹤0.01% | 571 |
|
|
2020
Q1 | $28K | Buy |
+1,042
| New | +$31.1K | ﹤0.01% | 538 |
|
|
2019
Q3 | $42K | Buy |
1,121
+18
| +2% | +$687 | ﹤0.01% | 557 |
|
|
2019
Q2 | $48K | Sell |
1,103
-56
| -5% | -$2.4K | ﹤0.01% | 438 |
|
|
2019
Q1 | $49K | Sell |
1,159
-67
| -5% | -$3K | ﹤0.01% | 425 |
|
|
2018
Q4 | $55K | Buy |
1,226
+5
| +0.4% | +$262 | ﹤0.01% | 401 |
|
|
2018
Q3 | $84K | Sell |
1,221
-4
| -0.3% | -$257 | ﹤0.01% | 343 |
|
|
2018
Q2 | $70K | Sell |
1,225
-324
| -21% | -$17.1K | ﹤0.01% | 380 |
|
|
2018
Q1 | $71K | Sell |
1,549
-54
| -3% | -$2.56K | ﹤0.01% | 381 |
|
|
2017
Q4 | $74K | Sell |
1,603
-32
| -2% | -$1.47K | ﹤0.01% | 373 |
|
|
2017
Q3 | $74K | Sell |
1,635
-13
| -0.8% | -$555 | ﹤0.01% | 376 |
|
|
2017
Q2 | $65K | Sell |
1,648
-243
| -13% | -$9.18K | ﹤0.01% | 392 |
|
|
2017
Q1 | $72K | Sell |
1,891
-455
| -19% | -$17.7K | ﹤0.01% | 365 |
|
|
2016
Q4 | $87K | Sell |
2,346
-144
| -6% | -$5.15K | ﹤0.01% | 334 |
|
|
2016
Q3 | $86K | Sell |
2,490
-206
| -8% | -$7.21K | ﹤0.01% | 334 |
|
|
2016
Q2 | $88K | Sell |
2,696
-171
| -6% | -$5.24K | ﹤0.01% | 325 |
|
|
2016
Q1 | $82K | Sell |
2,867
-299
| -9% | -$7.97K | ﹤0.01% | 331 |
|
|
2015
Q4 | $106K | Sell |
3,166
-655
| -17% | -$20.4K | 0.01% | 309 |
|
|
2015
Q3 | $109K | Sell |
3,821
-587
| -13% | -$20.5K | 0.01% | 306 |
|
|
2015
Q2 | $179K | Sell |
4,408
-1,098
| -20% | -$49.3K | 0.01% | 268 |
|
|
2015
Q1 | $271K | Sell |
5,506
-2,147
| -28% | -$99.5K | 0.01% | 232 |
|
|
2014
Q4 | $348K | Buy |
+7,653
| New | +$301K | 0.02% | 213 |
|
Other funds holding AVNS
RC
WHG
PIM
Bartlett & Co's AVNS Position: Q4 2023 in Review
Bartlett & Co reduced its Avanos Medical (AVNS) stake by 59% in Q4 2023, selling an estimated $2.58K and leaving 87 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1141.
Bartlett & Co first reported a position in AVNS in Q4 2014 and has held it in 35 quarters since. The position peaked at $348K in Q4 2014. 265 funds tracked by Wall St. Rank hold AVNS as of Q4 2023.
- Bartlett & Co held 87 shares of Avanos Medical worth $2K as of Q4 2023.
- Bartlett & Co sold 125 Avanos Medical shares in Q4 2023, an estimated $2.58K.
- Avanos Medical made up ﹤0.01% of Bartlett & Co's portfolio in Q4 2023, its #1141 holding.
- Bartlett & Co first reported a position in Avanos Medical in Q4 2014 and has held it in 35 quarters since.
- Bartlett & Co's Avanos Medical position peaked at $348K in Q4 2014.
- 265 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2023.
Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.